Mirae Asset Global Investments
RPTX

Mirae Asset Global Investments’s Repare Therapeutics RPTX Stock Holding History

Mirae Asset Global Investments’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60,068
Closed -$729K – 2587
2022
Q3 		$729K Buy
+60,068
New +$773K ﹤0.01% 1662

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mirae Asset Global Investments's RPTX Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of Repare Therapeutics (RPTX) in Q4 2022, closing a stake of 60,068 shares — an estimated $729K sold.

Mirae Asset Global Investments first reported a position in RPTX in Q3 2022 and held it in 1 quarter. The position peaked at $729K in Q3 2022. 82 funds tracked by Wall St. Rank hold RPTX as of Q4 2022.

  • Mirae Asset Global Investments reported no remaining Repare Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 60,068 Repare Therapeutics shares in Q4 2022, an estimated $729K.
  • Mirae Asset Global Investments first reported a position in Repare Therapeutics in Q3 2022 and held it in 1 quarter.
  • Mirae Asset Global Investments's Repare Therapeutics position peaked at $729K in Q3 2022.
  • 82 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.